Pharmaceutical Business review

Bioniche total revenues fall in FY 11

The company has posted net loss of C$15.35m, as compared to net loss of C$1.59m for the year ago period.

The basic and fully-diluted net loss per share for fiscal 2011 is ($0.17), as compared to a net loss per share of ($0.02) in Fiscal 2010.

Bioniche is a Canada-based developer, manufacturer and marketer of proprietary products for human and animal health markets worldwide.